Picture of Cellectis SA logo

ALCLS — Cellectis SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-18.5%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-72.44%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Cellectis SA EPS forecast chart

Profile Summary

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
January 1st, 2000
Public Since
February 6th, 2007
No. of Employees
340
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
45,461,310

ALCLS Share Price Performance

Latest News for ALCLS

Upcoming Events for ALCLS

Cellectis SA at JMP Group Hematology and Oncology Summit (Virtual)

Cellectis SA at American Society of Hematology (ASH)

Cellectis SA at Cell Therapy Analytical Development Summit

Q4 2021 Cellectis SA Earnings Release

Q1 2022 Cellectis SA Earnings Release

Similar to ALCLS

Picture of Abionyx Pharma SA logo

Abionyx Pharma SA

fr flag iconEuronext - Paris

Picture of Abivax SA logo

Abivax SA

fr flag iconEuronext - Paris

Acticor Biotech SAS

fr flag iconEuronext - Paris

Picture of Adocia SA logo

Adocia SA

fr flag iconEuronext - Paris

Picture of Biophytis SA logo

Biophytis SA

fr flag iconEuronext - Paris

FAQ

Or unlock with your email

Or unlock with your email